Cost comparison · China vs Singapore
Proton / heavy-ion therapy: China vs Singapore
Singapore is the regional benchmark for international medical care; China offers comparable Class A clinical quality at 40–55% of Singapore prices for major surgical procedures. Below is the procedure-specific cost band, what each price includes, and the line-by-line difference.
Side-by-side cost
All-in international-patient pricing in USD. Final quote depends on case complexity, implant choice and length of stay.
| Country | Typical price (USD) | Notes |
|---|---|---|
| China (Class A) | 35,000 – 85,000 | Proton USD 35–55k; heavy-ion USD 55–85k |
| Singapore | 65,000 – 120,000 | — |
What's included in the China price
- Multidisciplinary tumour board review
- Treatment planning (CT simulation, fusion with diagnostic imaging)
- Full course of proton or carbon-ion fractionation
- Daily on-treatment monitoring + weekly assessment
- Post-treatment imaging follow-up at month 3 / 6 / 12
Length of stay
35–60 days in country. Fly-home clearance typically at day 1–7 post-procedure.
Outcomes signal
- SPHIC is one of few centres globally with operational dual proton + carbon-ion treatment
- Outcomes for paediatric CNS tumours, skull base chordomas / chondrosarcomas, hepatocellular carcinoma, and recurrent / radioresistant disease consistent with international benchmarks
Frequently asked
- How much cheaper is proton / heavy-ion therapy in China vs Singapore?
- Proton / heavy-ion therapy in China typically costs $35,000–$85,000 USD all-in, vs $65,000–$120,000 USD in Singapore — a saving of roughly -31–71% before travel.
- What's included in the China price?
- Multidisciplinary tumour board review; Treatment planning (CT simulation, fusion with diagnostic imaging); Full course of proton or carbon-ion fractionation; Daily on-treatment monitoring + weekly assessment; Post-treatment imaging follow-up at month 3 / 6 / 12.
- Are clinical outcomes comparable?
- SPHIC is one of few centres globally with operational dual proton + carbon-ion treatment Outcomes for paediatric CNS tumours, skull base chordomas / chondrosarcomas, hepatocellular carcinoma, and recurrent / radioresistant disease consistent with international benchmarks Class A international departments report outcomes comparable to OECD benchmarks for elective procedures.
Compare Proton / heavy-ion therapy cost vs other countries
Get a written proton / heavy-ion therapy quote in 5 business days
Submit your case with recent imaging and medical records. We return two competing quotes from Class A partner hospitals — broken out line-by-line, no obligation.